Abstract
The objective of this study was to assess the pharmacokinetics and pharmacodynamics of the dextro (d-) isomer of sotalol, a class III antiarrhythmic agent, in healthy young men and women after a single intravenous bolus dose. The design was open-label, randomized, parallel group. Each group (4 men and 4 women) received either 0.5, 1.5, or 3.0 mg/kg d-sotalol as an intravenous infusion for 2 minutes. Serial measurements of the d-sotalol plasma concentration and the Q-Tc interval data were recorded before, during, and for 72 hours after drug administration. The pharmacokinetics of d-sotalol were found to be well described by a three-compartment model with linear elimination clearance from the central compartment. There were no significant differences in the elimination clearance or volume of the central compartment between dose levels or between men and women. However, women were found to have a lower steady-state volume of distribution than men (1.20 L/Kg versus 1.43 L/Kg). The Q-Tc versus d-sotalol plasma concentration data were fitted to a model that assumed a distinct "effect compartment" and sigmoidal Emax response. The baseline Q-Tc, determined from the fittings, was found to be significantly higher in women (0.40 versus 0....Continue Reading
References
Mar 22, 1976·European Journal of Clinical Pharmacology·H C BrownR G Shanks
Oct 1, 1992·Clinical Pharmacology and Therapeutics·F Le CozP Jaillon
Apr 1, 1991·Cardiovascular Drugs and Therapy·M ZehenderH Just
Dec 16, 1986·European Journal of Pharmacology·A W Gomoll, M J Bartek
Jul 1, 1987·Journal of the American College of Cardiology·J M McCombH Garan
Nov 1, 1981·Clinical Pharmacokinetics·N H Holford, L B Sheiner
Jul 1, 1994·The Journal of Pharmacy and Pharmacology·T UematsuM Nakashima
Jul 7, 1994·The New England Journal of Medicine·S H Hohnloser, R L Woosley
Dec 1, 1993·JAMA : the Journal of the American Medical Association·R R MakkarM H Lehmann
Jul 1, 1993·Clinical Pharmacology and Therapeutics·W J Jusko
Apr 1, 1993·Clinical Pharmacology and Therapeutics·S U YasudaR L Woosley
Jul 6, 1996·Lancet·A L WaldoE P Veltri
Citations
Jan 9, 2014·The AAPS Journal·Feras Khalil, Stephanie Läer
Jan 10, 2002·Journal of Pharmaceutical Sciences·Bernd Meibohm, Hartmut Derendorf
Sep 25, 2012·Journal of Electrocardiology·Norman StockbridgeMarek Malik
Dec 18, 2003·Journal of Cardiovascular Electrophysiology·John KassotisJames Coromilas
Dec 21, 2007·Journal of Clinical Pharmacology·Christine E GarnettJogarao V Gobburu
Jan 29, 2011·British Journal of Clinical Pharmacology·Daniel F B WrightStephen B Duffull
Apr 10, 2016·The AAPS Journal·Angela VilligerMartin Kuentz
Jul 25, 2012·Therapeutic Delivery·Flavia FranconiGiuseppe Rosano
Feb 28, 2020·Chirality·Vinod Kumar Vashistha, Anuj Kumar
Aug 22, 2012·British Journal of Clinical Pharmacology·Rashmi R Shah, Joel Morganroth
Nov 26, 2011·Expert Review of Clinical Pharmacology·Ameeta ParekhDouglas C Throckmorton
Oct 30, 2020·Journal of Pharmacokinetics and Pharmacodynamics·Georg FerberJiang Liu
Jun 12, 2021·Critical Care : the Official Journal of the Critical Care Forum·Josée BouchardUNKNOWN EXTRIP workgroup